PhaseRx Inc sell stratec
Start price
11.12.17
/
50%
?0.49
Target price
12.01.18
€0.27
Performance (%)
0.00%
End price
12.01.18
€0.24
Summary
This prediction ended on 12.01.18 with a price of €0.24. The SELL prediction by stratec closed unchanged from the start price. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
PhaseRx Inc | - | - | - | - |
iShares Core DAX® | -1.958% | 4.037% | 23.702% | 22.534% |
iShares Nasdaq 100 | 0.272% | 8.670% | 28.181% | 41.859% |
iShares Nikkei 225® | 0.377% | 7.232% | 21.118% | 9.739% |
iShares S&P 500 | 0.370% | 6.511% | 29.221% | 41.850% |
Comments by stratec for this prediction
In the thread PhaseRx Inc diskutieren
PhaseRx declares Chapter 11; shares down 48%
PhaseRx (PZRX -47.5%) slumps on increased volume in response to its announcement that
it intends to file for Chapter 11 bankruptcy protection. It will
continue its operations while it explores strategic alternatives. Cowen
and Company is advising.
(Zielkurs erreicht)